Billionaires Holding KMDA

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.07
    Yield

  • 32.2M
    Shares Outstanding

  • 151.73M
    Market Cap

News & Insights

ABOUT

KMDA

Kamada Ltd. develops, produces, and markets specialty plasma-derived protein therapeutics. It operates through two segments, Proprietary Products and Distribution. The company’s respiratory products include Glassia used in augmentation and maintenance therapy in adults with emphysema due to conge...

Introducing The New Elon Musk Strategy

NEWS

iBillionaire Joins Forces With IBM Watson

READ MORE